NuGen Medical Devices Key Fundamental Indicators
| NGMDF Stock | USD 0.02 0.0003 1.20% |
As of the 29th of January, NuGen Medical secures the mean deviation of 0.925, and Risk Adjusted Performance of (0.16). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NuGen Medical Devices, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down twelve technical drivers for NuGen Medical, which can be compared to its peers in the industry. Please verify NuGen Medical Devices coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and value at risk to decide if NuGen Medical Devices is priced some-what accurately, providing market reflects its recent price of 0.0247 per share. As NuGen Medical Devices appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.
NuGen Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing NuGen Medical's valuation are provided below:NuGen Medical Devices does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. NuGen |
NuGen Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NuGen Medical's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NuGen Medical.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in NuGen Medical on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding NuGen Medical Devices or generate 0.0% return on investment in NuGen Medical over 90 days. NuGen Medical is related to or competes with Comprehensive Healthcare. NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug del... More
NuGen Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NuGen Medical's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NuGen Medical Devices upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 13.41 | |||
| Value At Risk | (1.20) |
NuGen Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NuGen Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NuGen Medical's standard deviation. In reality, there are many statistical measures that can use NuGen Medical historical prices to predict the future NuGen Medical's volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | 0.7787 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NuGen Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NuGen Medical January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.16) | |||
| Market Risk Adjusted Performance | 0.7887 | |||
| Mean Deviation | 0.925 | |||
| Coefficient Of Variation | (447.33) | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.88 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (0.66) | |||
| Treynor Ratio | 0.7787 | |||
| Maximum Drawdown | 13.41 | |||
| Value At Risk | (1.20) | |||
| Skewness | (4.78) | |||
| Kurtosis | 23.16 |
NuGen Medical Devices Backtested Returns
NuGen Medical Devices has Sharpe Ratio of -0.22, which conveys that the firm had a -0.22 % return per unit of risk over the last 3 months. NuGen Medical exposes nineteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NuGen Medical's risk adjusted performance of (0.16), and Mean Deviation of 0.925 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of -0.65, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning NuGen Medical are expected to decrease at a much lower rate. During the bear market, NuGen Medical is likely to outperform the market. At this point, NuGen Medical Devices has a negative expected return of -0.49%. Please make sure to verify NuGen Medical's information ratio and the relationship between the value at risk and price action indicator , to decide if NuGen Medical Devices performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
NuGen Medical Devices has no correlation between past and present. Overlapping area represents the amount of predictability between NuGen Medical time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NuGen Medical Devices price movement. The serial correlation of 0.0 indicates that just 0.0% of current NuGen Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.8 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, NuGen Medical Devices has a Return On Equity of -14.7202. This is 38.59% lower than that of the Healthcare sector and 68.62% higher than that of the Medical Devices industry. The return on equity for all United States stocks is notably higher than that of the company.
NuGen Medical Devices Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuGen Medical's current stock value. Our valuation model uses many indicators to compare NuGen Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuGen Medical competition to find correlations between indicators driving NuGen Medical's intrinsic value. More Info.NuGen Medical Devices is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NuGen Medical's earnings, one of the primary drivers of an investment's value.NuGen Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuGen Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of NuGen Medical could also be used in its relative valuation, which is a method of valuing NuGen Medical by comparing valuation metrics of similar companies.NuGen Medical is currently under evaluation in return on equity category among its peers.
NuGen Fundamentals
| Return On Equity | -14.72 | |||
| Return On Asset | -0.42 | |||
| Operating Margin | (29.06) % | |||
| Current Valuation | 7.67 M | |||
| Shares Outstanding | 96.56 M | |||
| Shares Owned By Insiders | 19.15 % | |||
| Price To Book | 9.94 X | |||
| Price To Sales | 13.04 X | |||
| Revenue | 137.65 K | |||
| Gross Profit | 47.3 K | |||
| EBITDA | (5.09 M) | |||
| Net Income | (7.11 M) | |||
| Cash And Equivalents | 87.48 K | |||
| Total Debt | 5.61 M | |||
| Debt To Equity | 7.40 % | |||
| Current Ratio | 0.45 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (4.1 M) | |||
| Earnings Per Share | (0.08) X | |||
| Market Capitalization | 5.74 M | |||
| Total Asset | 8.84 M | |||
| Z Score | 0.6 | |||
| Net Asset | 8.84 M |
About NuGen Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuGen Medical Devices's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuGen Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuGen Medical Devices based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in NuGen OTC Stock
NuGen Medical financial ratios help investors to determine whether NuGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGen with respect to the benefits of owning NuGen Medical security.